 |
Email the Society |
 |
Donations |
ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
Mailing address:
GPO Box 383,
Adelaide,
South Australia 5001
Office:
266 Port Road,
Hindmarsh,
South Australia 5007
Ph: (08) 8346 3237
('834 MECFS')
Office Hours:
Wednesdays, 10am-3pm
Support Line:
(Mondays and Thursdays,
10am-3pm)
Ph: (08) 8346 3237
SA country callers:
Ph: 1300 128 339
(local call)
FIBROMYALGIA HELP: Contact Fibromyalgia SA at the Arthritis Foundation of SA 118 Richmond Road, Marleston 5033 Ph: (08) 8379 5711 |
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
|
Disclaimer
ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
| Become a Member | |||
|
Brain imaging study sheds light on Fibromyalgia
Sunday 21 June 2009
Brain imaging study sheds light on Fibromyalgia
Link found between gray matter and dopamine levels in patients
Changes in the levels of the neurotransmitter dopamine may explain brain gray matter reductions experienced by patients with fibromyalgia, a new study suggests.
Previous research found an association between fibromyalgia and reductions in gray matter, but the cause wasn't known, the researchers wrote.
In this new study, Dr. Patrick B. Wood, of Louisiana State University Health Sciences Center-Shreveport, and colleagues used MRI to compare the brains of 30 women with fibromyalgia and 20 healthy women of the same age. Significant reductions in gray matter were found in the fibromyalgia patients, confirming previous findings.
The new study, published in the June issue of the Journal of Pain, also found that fibromyalgia patients showed a strong correlation of dopamine metabolism levels and gray matter density in areas of the brain where dopamine is known to control neurological activity.
This association between dopamine levels and gray matter density offer new information about a possible mechanism behind some of the brain abnormalities seen in fibromyalgia patients, the researchers concluded.
More information
The American College of Rheumatology has more about fibromyalgia.
SOURCE: American Pain Society, news release, June 16, 2009
The article originally appeared here.
blog comments powered by Disqus
|
More Fibromyalgia News |
Previous Page |
